サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1519703

大容量非経口（LVP）市場レポート：タイプ、容量、用途、エンドユーザー、地域別、2024年～2032年

Large Volume Parenteral Market Report by Type, Volume, Application, End Users, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 143 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
大容量非経口（LVP）市場レポート：タイプ、容量、用途、エンドユーザー、地域別、2024年～2032年
出版日: 2024年07月01日
発行: IMARC
ページ情報: 英文 143 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の大容量非経口（LVP）の市場規模は2023年に98億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに162億米ドルに達し、2024年から2032年の間に5.6%の成長率（CAGR）を示すと予測しています。

大容量非経口（LVP）は、加熱滅菌後にガラス瓶または容量100ml以上のフレキシブル容器に包装された単回投与注射剤です。皮膚などの外界組織から注射し、血管、臓器、組織、病変部などに薬効成分を直接投与します。一般に、有効成分、水混和性または非水性のビヒクル、および緩衝剤、抗酸化剤、防腐剤、界面活性剤、抗菌剤、強壮剤などの添加物質から構成されます。世界中で一般的に使用されているLVPには、腹膜透析液、灌流液、血液製剤、薬剤プレミックス、造影剤などがあります。

大容量非経口（LVP）市場の動向：

栄養不良の有病率の上昇、出生率の増加、世界の早産の増加は、経口摂取が困難な患者に大量の栄養素を投与するためのLVPの需要を喚起する主な要因の一つです。これとは別に、食道閉塞、胃腸（GI）疾患、がん、潰瘍の治療を受けている患者への必須栄養素の投与にも広く使用されています。さらに、LVPは心臓手術において、再灌流時の心筋虚血傷害や血流制限を防ぐために広く応用されています。このことは、外科的介入を受ける患者の間で安全で迅速かつ効果的な薬剤投与方法に対する需要が高まっていることと相まって、市場の成長に寄与しています。これに加えて、世界中でファストフードの消費が増加しているため、高血圧、糖尿病、肥満、その他の代謝異常などの非伝染性疾患が増加しています。これは、デキストロース、アミノ酸、脂質、添加電解質、微量金属、ビタミンの混合物であるLVPの採用にプラスの影響を与えています。

本レポートで扱う主な質問

  • 世界の大容量非経口（LVP）市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の大容量非経口（LVP）市場に与えた影響は？
  • 主要な地域市場は？
  • タイプ別の市場内訳は？
  • 容量ベースの市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の大容量非経口（LVP）市場の構造と主要プレーヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の大容量非経口（LVP）市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • ソフトバッグ LVP
    • 市場動向
    • 市場予測
  • プラスチックボトルLVP
    • 市場動向
    • 市場予測
  • ガラスボトルLVP
    • 市場動向
    • 市場予測

第7章 市場内訳：容量別

  • 100ML-250ML
    • 市場動向
    • 市場予測
  • 250ML-500ML
    • 市場動向
    • 市場予測
  • 500ML-1000ML
    • 市場動向
    • 市場予測
  • 1000ML-2000ML
    • 市場動向
    • 市場予測
  • 2000ML以上
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 治療用注射
    • 市場動向
    • 市場予測
  • 体液バランス注射
    • 市場動向
    • 市場予測
  • 栄養注射
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • クリニック
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Albert David Ltd.
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • BML Parenteral Drugs
    • Fresenius Kabi AG
    • Grifols S.A
    • Otsuka Pharmaceutical Co. Ltd
    • Pharmaceutical Solutions Industry Ltd.
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Large Volume Parenteral Market: Major Drivers and Challenges
  • Figure 2: Global: Large Volume Parenteral Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Large Volume Parenteral Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Large Volume Parenteral Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Large Volume Parenteral Market: Breakup by Volume (in %), 2023
  • Figure 6: Global: Large Volume Parenteral Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Large Volume Parenteral Market: Breakup by End Users (in %), 2023
  • Figure 8: Global: Large Volume Parenteral Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Large Volume Parenteral (Soft Bag LVP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Large Volume Parenteral (Soft Bag LVP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Large Volume Parenteral (Plastic Bottle LVP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Large Volume Parenteral (Plastic Bottle LVP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Large Volume Parenteral (Glass Bottle LVP) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Large Volume Parenteral (Glass Bottle LVP) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Large Volume Parenteral (100 ML - 250 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Large Volume Parenteral (100 ML - 250 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Large Volume Parenteral (250 ML - 500 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Large Volume Parenteral (250 ML - 500 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Large Volume Parenteral (500 ML - 1000 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Large Volume Parenteral (500 ML - 1000 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Large Volume Parenteral (1000 ML - 2000 ML) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Large Volume Parenteral (1000 ML - 2000 ML) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Large Volume Parenteral (2000 ML and More) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Large Volume Parenteral (2000 ML and More) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Large Volume Parenteral (Therapeutic Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Large Volume Parenteral (Therapeutic Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Large Volume Parenteral (Fluid Balance Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Large Volume Parenteral (Fluid Balance Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Large Volume Parenteral (Nutritious Injections) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Large Volume Parenteral (Nutritious Injections) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Large Volume Parenteral (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Large Volume Parenteral (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Large Volume Parenteral (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Large Volume Parenteral (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Large Volume Parenteral (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Large Volume Parenteral (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Large Volume Parenteral Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Large Volume Parenteral Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Large Volume Parenteral Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Large Volume Parenteral Industry: SWOT Analysis
  • Figure 87: Global: Large Volume Parenteral Industry: Value Chain Analysis
  • Figure 88: Global: Large Volume Parenteral Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Large Volume Parenteral Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Large Volume Parenteral Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Large Volume Parenteral Market Forecast: Breakup by Volume (in Million US$), 2024-2032
  • Table 4: Global: Large Volume Parenteral Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 5: Global: Large Volume Parenteral Market Forecast: Breakup by End Users (in Million US$), 2024-2032
  • Table 6: Global: Large Volume Parenteral Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Large Volume Parenteral Market: Competitive Structure
  • Table 8: Global: Large Volume Parenteral Market: Key Players
目次
Product Code: SR112024A5711

The global large volume parenteral (LVP) market size reached US$ 9.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 16.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.6% during 2024-2032.

A large volume parenteral (LVP) is a single-dose injection packaged in a glass bottle or a flexible container of more than 100ml capacity after sterilization via heat. It is injected through the skin or other external boundary tissue to directly administrate the active drug substances into the blood vessels, organs, tissues, or lesions. It generally consists of an active ingredient, water-miscible or non-aqueous vehicle, and added substances like buffers, antioxidants, preservatives, surfactants, antimicrobial agents, and tonicity adjusters. Some of the commonly available LVPs around the world are peritoneal dialysis, irrigating solutions, blood derivatives, drug premixes, and contrast agents.

Large Volume Parenteral (LVP) Market Trends:

The rising prevalence of malnutrition, growing natality rate, and increasing premature births worldwide are among the key factors catalyzing the demand for LVPs to administer a large amount of nutrients in patients who are unable to take food orally. Apart from this, they are widely used in administering essential nutrients to patients undergoing treatment for esophageal obstruction, gastrointestinal (GI) diseases, cancer, and ulcer. In addition, LVPs find extensive application in heart surgery to prevent ischemic injury to the myocardium during reperfusion and the blood flow supply restriction. This, in confluence with the escalating demand for safe, fast, and effective methods of drug administration among patients undergoing surgical interventions, is contributing to the market growth. Besides this, the growing consumption of fast food across the globe has resulted in rising instances of non-communicable diseases, such as hypertension, diabetes, obesity, and other metabolic disorders. This, in turn, is positively influencing the adoption of LVPs that are a mixture of dextrose, amino acids, lipids, added electrolytes, trace metals, and vitamins.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global large volume parenteral (LVP) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, volume, application and end users.

Breakup by Type:

Soft Bag LVP

Plastic Bottle LVP

Glass Bottle LVP

Breakup by Volume:

100 ML - 250 ML

250 ML - 500 ML

500 ML - 1000 ML

1000 ML - 2000 ML

2000 ML and More

Breakup by Application:

Therapeutic Injections

Fluid Balance Injections

Nutritious Injections

Breakup by End Users:

Hospitals

Clinics

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Albert David Ltd., B. Braun Melsungen AG, Baxter International Inc., BML Parenteral Drugs, Fresenius Kabi AG, Grifols S.A, Otsuka Pharmaceutical Co. Ltd, Pharmaceutical Solutions Industry Ltd., Sichuan Kelun Pharmaceutical Co. Ltd. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global large volume parenteral (LVP) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global large volume parenteral (LVP) market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the volume?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end users?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global large volume parenteral (LVP) market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Large Volume Parenteral (LVP) Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Soft Bag LVP
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Plastic Bottle LVP
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Glass Bottle LVP
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Volume

  • 7.1 100 ML - 250 ML
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 250 ML - 500 ML
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 500 ML - 1000 ML
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 1000 ML - 2000 ML
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 2000 ML and More
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Therapeutic Injections
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Fluid Balance Injections
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutritious Injections
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End Users

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Albert David Ltd.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 B. Braun Melsungen AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Baxter International Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4 BML Parenteral Drugs
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Fresenius Kabi AG
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Grifols S.A
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Otsuka Pharmaceutical Co. Ltd
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pharmaceutical Solutions Industry Ltd.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Sichuan Kelun Pharmaceutical Co., Ltd.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Thermo Fisher Scientific Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis